– Publication explores structure-activity relationships (“SAR”) of a broad range of 2C-X analogs – – Innovative research led to the discovery of CYB210010, a potent and long-acting serotonin 5-HT2 receptor agonist with favorable pharmacokinetic properties – TORONTO — Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”…
Read More
About The Author
